Apoptosis

Eribulin mesylate View larger

Eribulin mesylate

AT13687

CAS 441045-17-6

More details

Molarity Calculation Cart®

HOW TO ORDER

$366.00

$366.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $164.70 Total: $16,470.00
150 $190.32 Total: $9,516.00
125 $223.26 Total: $5,581.50
110 $263.52 Total: $2,635.20
15 $311.10 Total: $1,555.50

Data sheet

Molecular FormulaC41H63NO14S
Molecular Weight826
CAS Numbers441045-17-6
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeCS(O)(=O)=O.[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2
ReferencesOkouneva, T., et al., Inhibition of centromere dynamics by eribulin [E7389] during mitotic metaphase. Mol Cancer Ther, 2008. 7[7] p. 2003-11.

More info

Eribulin mesylate (E7389 mesylate) (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.